Evercore ISI raised the firm’s price target on Walgreens Boots Alliance to $25 from $21 and keeps an In Line rating on the shares, noting that the company’s Q4 and FY24 guidance “came in largely as expected.” The firm views the updated FY24 EPS guidance of $3.20-$3.50 as “a reasonable starting point for the year” and with expectations reset for FY24, an improved/more focused U.S. Healthcare strategy, and Tim Wentworth about to start, Evercore sees the potential for short term positive momentum in the name, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on WBA:
- Walgreens Boots Alliance price target lowered to $26 from $29 at RBC Capital
- Walgreens Boots Alliance price target lowered to $22 from $24 at BofA
- Early notable gainers among liquid option names on October 12th
- Unusually active option classes on open October 12th
- Walgreens Boots Alliance new CEO ‘an incremental positive,’ says BofA